The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
02-Mar-98
$400 million
Target:
Olsy SpA (Olivetti SpA)
Acquiror:
Wang Laboratories Inc.
Advised Wang on its acquisition of Olsy, the systems and solutions division of Olivetti, for a combination of cash and securities.
06-Aug-99
$12.8 billion
Target:
One2One
Acquiror:
Deutsche Telekom AG
(joint venture between Cable and Wireless plc and Media One)
Strategic advice to C&W in connection with the sale of One2One, a UK mobile phone operator, 50% owned by C&W and 50% owned by Media One
25-Mar-01
$9.7 billion
Target:
Cable & Wireless Optus Limited
Acquiror:
Singapore Telecommunications Limited
, 52.5% subsidiary of Cable and Wireless plc Advised C&W on the sale of its 52.5% owned Australian subsidiary, Cable & Wireless Optus, to SingTel
30-Jul-01
$117 million
Target:
Kymata Ltd.
Acquiror:
Alcatel Optronics
Advised Kymata Ltd, the Scottish manufacturer of optical components, on its sale to Alcatel Optronics of France.
24-Mar-06
$21.2 billion
Target:
Schering AG
Acquiror:
Bayer AG
Advised Bayer on its public offer for Schering, an international pharmaceuticals group based in Berlin, Germany
19-Dec-06
$270 million
Target:
Brion Technologies, Inc.
Acquiror:
ASML Holding N.V.
Advised ASML Holding N.V., a leading provider of lithography systems for the semiconductor industry, on its acquisition of Brion Technologies, Inc.
26-Mar-07
$1.0 billion
Target:
Wolters Kluwer Education
Acquiror:
Bridgepoint Capital Limited
Advised Bridgepoint Capital Limited on its acquisition of Wolters Kluwer Education, the pan-European educational publishing division of quoted Dutch-based information services and publishing company Wolters Kluwer NV
03-May-07
$8.5 billion
Target:
IPSCO Inc.
Acquiror:
SSAB Svenskt Stål AB
Acted as lead financial advisor to SSAB Svenskt Stål AB on its acquisition of IPSCO Inc., a leading Canadian producer of energy tubulars and steel plate in North America with an annual steel making capacity of 4.3 million tons
02-Jan-08
$NA
Target:
E. Brost & J. Funke GmbH & Co. KG (BFK KG) and its 25% stake in Otto Group
Acquiror:
Otto AG für Beteiligungen (investment vehicle of Otto family)
Advised the shareholders of BFK KG, comprising the families who also own German publisher WAZ Media Group, on the sale of their 25% holding in German retailing and services group Otto to the Otto family, which thereby regained full ownership of the business
22-Jan-08
$3.4 billion
Target:
Ventana Medical Systems, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of Ventana Medical Systems, Inc., a US based provider of histopathology diagnostic equipment
05-Aug-08
$NA
Target:
BARTEC Group
Acquiror:
Capvis
Advised Capvis, a leading Swiss private equity firm, on its acquisition of the BARTEC Group, a leading European provider of industrial safety technology, from Allianz Capital Partners, the captive private equity arm of Allianz AG, and the Barlian family (founding family)
06-Aug-08
$10.7 billion
Target:
Lonmin plc
Acquiror:
Xstrata plc
Advised Lonmin plc, a major producer of Platinum Group Metals, regarding an unsolicited pre-conditional offer for the company by Xstrata plc, a global diversified mining company
07-Aug-08
$NA
Target:
Scholastic Corporation’s US direct-to-home continuities business
Acquiror:
Sandvik AS
Advised Scholastic, the global children’s publishing, education and media company, on the sale of its US direct-to-home continuities business to Sandvik AS
15-Sep-08
$189 million
Target:
Fermat International
Acquiror:
Moody’s Corporation
Advised Moody’s Corporation on its acquisition of Fermat International, a leading provider of risk and performance management software to the global banking sector
01-Oct-08
$53 million
Target:
Biotage (Biosystems division)
Acquiror:
Qiagen NV
Advised Biotage AB (OMX: BIOT), a global biotechnology company, on its strategic review resulting in the disposal of its Biosystems division which offers systems for genetic analysis mainly for use in clinical research
12-Mar-09
$46.9 billion
Target:
Genentech, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company
09-Nov-09
$327 million
Target:
Enzon Pharmaceuticals, Inc.
Acquiror:
Sigma-Tau Pharmaceuticals
Advised Enzon Pharmaceuticals, Inc., a biopharmaceutical company on the sale of its specialty pharmaceutical business to Sigma-Tau, an Italian pharmaceutical company
04-Dec-09
$NA
Target:
Verivox Holding Limited
Acquiror:
Oakley Capital Private Equity LP
Advised the shareholders of Verivox Holdings Limited, comprising Independent News & Media plc and the founders and joint CEOs of Verivox, on the sale of 51% in Verivox, Germany’s leading price comparison website for energy and telecommunications services, to Oakley Capital Private Equity
01-Apr-10
$9.2 billion
Target:
Lihir Gold Limited
Acquiror:
Newcrest Mining Ltd
Advised Lihir Gold Limited, a leading global gold company with operations in Papua New Guinea, Australian and West Africa on an unsolicited takeover proposal from Newcrest Mining Ltd, an international gold company with gold and copper operations
01-Jul-10
$NA
Target:
Media Monitors
Acquiror:
Quadrant Private Equity
Advised Media Monitors, the leading media intelligence company in Asia-Pacific, on its sale to Quadrant Private Equity
29-Jul-10
$328 million
Target:
Mitchell Communication Group Limited
Acquiror:
Aegis Group plc
Advised Aegis Group plc on its acquisition of Mitchell Communication Group Limited, Australia’s leading independent media buyer
26-Nov-10
$118 million
Target:
Healthcare Australia
Acquiror:
Healthcare Locums
Advised CHAMP Private Equity on the sale of Healthcare Australia, a leading provider of nursing agency staff to public and private health institutions in Australia, to Healthcare Locums, a healthcare recruitment agency based in the UK
15-Dec-10
$12.9 billion
Target:
Alcon, Inc.
Acquiror:
Novartis AG
Advised the Independent Director Committee of Alcon, Inc., an ophthalmic pharmaceutical company, on the sale of Alcon’s outstanding publicly held interest to Novartis AG, a global pharmaceutical company
14-Feb-11
$40.0 billion
Target:
Australian National Broadband Network
Greenhill acted as sole adviser to the Australian government in connection with the National Broadband Network, which represents the single largest infrastructure project in the country’s history
13-May-11
$NA
Target:
Bionomics Ltd
Advised Bionomics Ltd, in relation to the tender process run by Bionomics’ largest shareholder, Start-up Australia Ventures (“Start-up”), for its 28% stake in the company, follow on sell-down of Start-up’s stake to 8% and associated capital raising by Bionomics